Thanks for your post Mozz. Great idea. Hopefully the power of numbers will result in one or two of our questions being answered.
I think a key question has to be regarding the point that teddywestside88 touched on in the NWR Virtual Conference announcement thread earlier today. There was a reference in one of the NWR Virtual presentation slides to a Ph3 sample size of 1650 people (950 + 700 confirmatory).As we all know a total Ph3 sample size n=1150(750 + 400) was announced April 8th 2020 in the CR presentation. Ithink our question should be to please clarify the sample size for Phase 3given the reference of a larger sample size in the NWR Virtual presentation. Ifthe sample size has materially increased from 1150 please explain the rationaleand is the company still fully funded for an expanded Phase 3 trial?
Well done on Teddy for seeing the slide that PR was about to speak to before he ran out of time. When I replayed the presentation I think the slide only appeared for about a second. It is a shame PR ran out of time and didn’t get a chance to talk to the slide.
Thanks for your post Mozz. Great idea. Hopefully the power of...
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.005(1.64%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $98.05K | 323.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29159 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 4999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |